Long COVID
News
‘Breakthrough’ study: Diabetes drug helps prevent long COVID
Metformin led to a 42% drop in long COVID among people who had a mild to moderate COVID-19 infection.
Clinical Topics & News
Even mild COVID is hard on the brain
New study results suggest a severe pattern of changes in how the brain communicates as well as its structure in people with anxiety and depression...
News
Is cellular senescence related to post–COVID-19 syndrome?
Patients with a diagnosis of clinical aspects associated with PASC at 6 months were characterized by certain predisposing factors.
Conference Coverage
Metformin linked to reductions in COVID-19 viral load
Key questions the findings raise include whether the results correlate with clinical outcomes or transmission, and whether the findings are...
News
Inflammation and immunity troubles top long-COVID suspect list
“I think that it’s a much more complex picture than just inflammation, or just autoimmunity, or just immune dysregulation,” says expert.
News
Long COVID affecting more than one-third of college students, faculty
A new study is unique for evaluating mostly healthy, young adults and for its rare look at long COVID in a university community.
Opinion
Q&A with long COVID patient-researcher: Treatments lagging as cases rise
One thing that stood out is the review’s finding that long COVID is potentially lifelong COVID.
News
Add this to the list of long COVID symptoms: Stigma
Most people with long COVID find they’re facing stigma due to their condition, a new study finds.
News
Which treatments improve long-term outcomes of critical COVID illness?
“When looking at the impact of treatment, we don’t want to improve short-term outcomes yet worsen long-term disability. That long-term, 6-month...
News
Long COVID comes into focus, showing older patients fare worse
The findings of new research help define long COVID, according to the investigators.